Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

9.0K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.0K
Abnormal Proliferation02:23

Abnormal Proliferation

4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Tumor Progression02:07

Tumor Progression

6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

7.5K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nanopore sequencing technology in forensic science: status quo and tendency.

Annals of human biology·2026
Same author

CD70-targeted platform for diagnosing and treating multiple myeloma.

Journal for immunotherapy of cancer·2026
Same author

A deep learning model for real-time recognition of immature persimmons in complex field scenarios.

Frontiers in plant science·2026
Same author

IFN-γ induces hematopoietic stem cell myelopoiesis through Meis1 in tumor.

Stem cell research & therapy·2026
Same author

Chiral aroma compounds in alcoholic beverages: A review.

Food chemistry·2026
Same author

Morphomechanic tuning of ERK by actin-TFII-IΔ regulates cell identity.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Jul 27, 2025

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:39

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

182

Super-enhancer-associated gene CAPG promotes AML progression.

Qian Ma1, Minyi Zhao2, Bing Long3

  • 1Department of Clinical Laboratory, Peking University First Hospital, Beijing, China.

Communications Biology
|June 9, 2023
PubMed
Summary

Super-enhancers drive cancer progression in acute myeloid leukemia (AML). Targeting the super-enhancer-associated gene CAPG shows promise for overcoming drug resistance and improving AML treatment outcomes.

More Related Videos

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

10.0K
Investigation of Genetic Dependencies Using CRISPR-Cas9-based Competition Assays
11:05

Investigation of Genetic Dependencies Using CRISPR-Cas9-based Competition Assays

Published on: January 7, 2019

9.5K

Related Experiment Videos

Last Updated: Jul 27, 2025

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:39

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

182
Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

10.0K
Investigation of Genetic Dependencies Using CRISPR-Cas9-based Competition Assays
11:05

Investigation of Genetic Dependencies Using CRISPR-Cas9-based Competition Assays

Published on: January 7, 2019

9.5K

Area of Science:

  • Oncology
  • Epigenetics
  • Molecular Biology

Background:

  • Acute myeloid leukemia (AML) presents significant challenges due to refractory disease and drug resistance.
  • Abnormal gene expression and epigenetic alterations are key drivers in AML pathogenesis and treatment response.
  • Super-enhancers (SEs) are crucial epigenetic elements that can promote oncogene transcription, contributing to tumor progression and drug resistance.

Purpose of the Study:

  • To investigate the role of super-enhancer-associated genes in AML.
  • To elucidate the molecular function of the CAPG gene in AML progression.
  • To assess the therapeutic potential of targeting CAPG in AML.

Main Methods:

  • Multi-omics integrative analysis to identify SE-associated genes.
  • Proteomic and epigenomic analyses to determine CAPG's molecular function.
  • In vivo studies using an AML murine model with Capg knockdown.

Main Results:

  • A super-enhancer-associated gene, CAPG, was identified and found to be highly expressed in AML.
  • High CAPG expression correlates with poor prognosis in AML patients.
  • CAPG regulates the NF-κB signaling pathway.
  • Knockdown of Capg in an AML murine model led to AML cell exhaustion and prolonged survival.

Conclusions:

  • Super-enhancer-associated gene CAPG contributes to AML progression, potentially through the regulation of the NF-κB signaling pathway.
  • Targeting CAPG presents a potential therapeutic strategy for overcoming drug resistance in AML.
  • Further research into CAPG's function could reveal novel therapeutic targets for acute myeloid leukemia.